Mukka Proteins Limited (MUKKA.NS)
INR 39.8
(0.91%)
INR 39.8
(0.91%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.63 Billion | -655.31 Million | 1.81 Million | -5.73 Million | -297.89 Million | -237.41 Million |
| Net Income | 700.52 Million | 440.75 Million | 242.08 Million | 89.76 Million | 131.75 Million | 142.9 Million |
| Depreciation & Amortization | 123.38 Million | 118.51 Million | 85.38 Million | 83.02 Million | 46.91 Million | 24.29 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -2.33 Billion | -1.28 Billion | -365.42 Million | -153.51 Million | -452.12 Million | -394.6 Million |
| Other non-cash items | 2.62 Billion | 1.59 Billion | 429.71 Million | 439.49 Million | 495.86 Million | 500.48 Million |
| Investing Cash Flow | -527.54 Million | -53.83 Million | -142.25 Million | -144.07 Million | -289.74 Million | -237.64 Million |
| Investments in PPE | -176.19 Million | -82.15 Million | -65.11 Million | -106.77 Million | -363.95 Million | -190.52 Million |
| Acquisitions | 6.25 Million | 2.06 Million | 2.35 Million | 4.51 Million | - | 700 Thousand |
| Investment purchases | -396.54 Million | -9.25 Million | -100.99 Million | -82.55 Million | - | -57.49 Million |
| Sales/Maturities of investments | 31.06 Million | 33.93 Million | 18.18 Million | 38.21 Million | 67.91 Million | 6.33 Million |
| Other Investing Activities | 7.86 Million | 1.58 Million | 3.32 Million | 2.53 Million | 6.3 Million | 3.34 Million |
| Financing Cash Flow | 2.84 Billion | 859.26 Million | 224.25 Million | 175.18 Million | 595.04 Million | 382.69 Million |
| Debt repayment | -1.05 Billion | -869.64 Million | -228.49 Million | -175.18 Million | -588.04 Million | -374.61 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.8 Billion | - | - | - | 6.99 Million | 8.07 Million |
| Other Financing Activities | -24.09 Million | 56.34 Million | 94.1 Million | -8.67 Million | 10 Thousand | 10 Thousand |
| Accounts receivables | -624.77 Million | -999.07 Million | -44.12 Million | -136.5 Million | -393.27 Million | -155.65 Million |
| Accounts payables | 54.02 Million | 353.17 Million | -25.13 Million | 185.84 Million | 217.34 Million | 98.91 Million |
| Inventory | -1.93 Billion | -649.04 Million | -149.92 Million | -347.8 Million | -250.55 Million | -405.16 Million |
| Other working capital | 168.8 Million | 14.22 Million | -146.25 Million | 144.95 Million | -25.64 Million | 67.3 Million |
| Cash at beginning of period | 265.48 Million | 115.35 Million | 31.53 Million | 14.91 Million | 6.91 Million | 99.27 Million |
| Cash at end of period | 1.26 Billion | 265.48 Million | 115.35 Million | 31.53 Million | 14.91 Million | 6.91 Million |
| Capital Expenditure | -176.19 Million | -82.15 Million | -65.11 Million | -106.77 Million | -363.95 Million | -190.52 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1 Billion | 150.13 Million | 83.82 Million | 16.62 Million | 8 Million | -92.36 Million |
| Free Cash Flow | -1.81 Billion | -737.46 Million | -63.29 Million | -112.5 Million | -661.84 Million | -427.93 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 42.26 Million | 271.69 Million | 700.52 Million | 104.74 Million | 161.68 Million | 161.68 Million |
| Depreciation & Amortization | - | - | 123.38 Million | - | 30.36 Million | 30.36 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -2.33 Billion | - | -189.25 Million | -189.25 Million |
| Other non-cash items | -42.26 Million | -271.69 Million | 2.62 Billion | -104.74 Million | -103.39 Million | -103.39 Million |
| Investing Cash Flow | - | - | -527.54 Million | - | -204.72 Million | -204.72 Million |
| Investments in PPE | - | - | -176.19 Million | - | -37.36 Million | -37.36 Million |
| Acquisitions | - | - | 6.25 Million | - | - | - |
| Investment purchases | - | - | -396.54 Million | - | - | - |
| Sales/Maturities of investments | - | - | 31.06 Million | - | - | - |
| Other Investing Activities | - | - | 7.86 Million | - | -167.36 Million | -167.36 Million |
| Financing Cash Flow | - | - | 2.84 Billion | - | 268.26 Million | 268.26 Million |
| Debt repayment | - | - | -1.05 Billion | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 1.8 Billion | - | - | - |
| Other Financing Activities | - | - | -24.09 Million | - | 268.26 Million | 268.26 Million |
| Accounts receivables | - | - | -624.77 Million | - | -175.27 Million | -175.27 Million |
| Accounts payables | - | - | 54.02 Million | - | - | - |
| Inventory | - | - | -1.93 Billion | - | -2.98 Million | -2.98 Million |
| Other working capital | - | - | 168.8 Million | - | -10.99 Million | -10.99 Million |
| Cash at beginning of period | - | - | 265.48 Million | - | - | 265.48 Million |
| Cash at end of period | - | - | 1.26 Billion | - | -37.06 Million | 228.42 Million |
| Capital Expenditure | - | - | -176.19 Million | - | -37.36 Million | -37.36 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 1 Billion | - | -37.06 Million | -37.06 Million |
| Free Cash Flow | - | - | -1.81 Billion | - | -137.96 Million | -137.96 Million |
BSGM
003816
002327
002316
7953
INL